Viral Dynamics Matter in COVID-19 Pneumonia: the success of early treatment with hydroxychloroquine and azithromycin in Lebanon
HCQ+AZ potentially explains 94.7% success in treating a fairly complex cohort.
Chamieh et al., 28 May 2020, preprint, 10 authors.
Abstract: medRxiv preprint doi: https://doi.org/10.1101/2020.05.28.20114835; this version posted June 2, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .
1
Category : Original Article
2
Title: Viral Dynamics Matter in COVID-19 Pneumonia: the success of early treatment with
3
hydroxychloroquine and azithromycin in Lebanon.
4
5
Authors:
6
Amanda Chamieh1,2, Claude Afif2, Gerard El-Hajj3, Omar Zmerli2, Isabelle Djaffar-
7
Jureidini4, Roy A. Raad3, Raja Ashou3, Georges Juvelekian5, Jean-Marc Rolain1 and Eid
8
Azar2*
9
10
11
Affiliations:
1- Aix-Marseille Université, AP-HM, Institut de Recherche pour le Développement
12
(IRD), Microbes Evolution Phylogeny and Infections (MEPHI), Institut Hospitalo-
13
Universitaire Méditerranée-Infection, Marseille, France.
14
15
16
17
18
19
20
21
2- Division of Infectious Diseases, Saint George Hospital University Medical Center,
Beirut, Lebanon.
3- Department of Radiology, Saint George Hospital University Medical Center, Beirut,
Lebanon.
4- Department of Laboratory Medicine, Saint George Hospital University Medical
Center, Beirut, Lebanon.
5- Department of Pulmonary and Critical Care Medicine, Saint George Hospital
University Medical Center, Beirut, Lebanon.
22
23
Running Title: Viral Dynamics Matter in COVID-19 Pneumonia
24
25
Declarations of Interest and Funding/Support Statement:
3
NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.
medRxiv preprint doi: https://doi.org/10.1101/2020.05.28.20114835; this version posted June 2, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .
26
This research did not receive any specific grant from funding agencies in the public,
27
commercial, or not-for-profit sectors.
28
Acknowledgements:
29
This work was supported by the Saint George Hospital University Medical Center
30
Beirut, Lebanon.
31
*Corresponding Author:
32
Eid Azar, M.D.
33
Infectious Disease, Chief of Staff
34
Associate Chief Medical Officer for Safety, Risk Management, and Infection Prevention and
35
Control
36
Saint George Hospital University Medical Center, Youssef Sursock St. – Achrafieh, Beirut,
37
Lebanon; eeazar@stgeorgehospital.org; +961 03 665358
38
39
40
4
medRxiv preprint doi: https://doi.org/10.1101/2020.05.28.20114835; this version posted June 2, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .
41
Category: Original Article
42
43
Title: Viral Dynamics Matter in COVID-19 Pneumonia: the success of early treatment with
44
hydroxychloroquine and azithromycin in Lebanon.
45
46
Running Title: Viral Dynamics Matter in COVID-19 Pneumonia
5
medRxiv preprint doi: https://doi.org/10.1101/2020.05.28.20114835; this version posted June 2, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to..
Late treatment
is less effective
Please send us corrections, updates, or comments.
c19early involves the extraction of over 100,000 datapoints from
thousands of papers.
Community updates
help ensure high accuracy.
Vaccines and treatments are complementary. All practical, effective, and safe
means should be used based on risk/benefit analysis. No treatment, vaccine, or
intervention is 100% available and effective for all current and future
variants. We do not provide medical advice. Before taking any medication,
consult a qualified physician who can provide personalized advice and details
of risks and benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit